Sun Xiaoping, Gong Yun, Talamonti Mark S, Rao M Sambasiva
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Mod Pathol. 2002 Dec;15(12):1333-8. doi: 10.1097/01.MP.0000038464.44522.90.
Although all carcinoids are potentially malignant, their biologic behavior is quite variable. Currently there are no reliable morphological criteria to predict metastatic potential. Cell adhesion molecules, such as CD44 and E-cadherin, are considered important in regulating invasion and metastasis of tumors. Also, angiogenesis has been shown to be associated with tumor growth and progression. In this study, we examined 51 carcinoids, including 13 carcinoids with known lymph node and/or visceral metastasis, for expression of CD44s (the standard form of CD44) and E-cadherin by immunohistochemistry. We found that 55% and 37% of carcinoids were negative for CD44s and E-cadherin, respectively. Carcinoids with lymph node and/or visceral metastasis were significantly more frequently negative for CD44s than were those without demonstrated metastasis (P =.030). Ten of 11 tumors with lymph node metastasis lacked CD44s (P =.022), whereas E-cadherin was negative in only 3 (P =.975). Additionally, we analyzed microvessel density to evaluate the role of tumor angiogenesis in the tumor behavior. Carcinoid tumors in general demonstrated high microvessel density (160 +/- 82/five 200x fields), irrespective of location and with and without metastasis. These results suggest that loss of CD44s, but not E-cadherin, may be a useful predictor of metastatic potential of carcinoid tumors.
尽管所有类癌都有潜在的恶性可能,但其生物学行为差异很大。目前尚无可靠的形态学标准来预测转移潜能。细胞黏附分子,如CD44和E-钙黏蛋白,被认为在调节肿瘤的侵袭和转移中起重要作用。此外,血管生成已被证明与肿瘤生长和进展相关。在本研究中,我们通过免疫组织化学检测了51例类癌,包括13例已知有淋巴结和/或内脏转移的类癌,以检测CD44s(CD44的标准形式)和E-钙黏蛋白的表达。我们发现,分别有55%和37%的类癌CD44s和E-钙黏蛋白呈阴性。有淋巴结和/或内脏转移的类癌CD44s阴性的频率显著高于无转移的类癌(P = 0.030)。11例有淋巴结转移的肿瘤中有10例缺乏CD44s(P = 0.022),而E-钙黏蛋白仅3例呈阴性(P = 0.975)。此外,我们分析了微血管密度以评估肿瘤血管生成在肿瘤行为中的作用。总体而言,类癌肿瘤显示出高微血管密度(160±82/五个200倍视野),无论其位置以及有无转移。这些结果表明,CD44s的缺失而非E-钙黏蛋白的缺失可能是类癌肿瘤转移潜能的一个有用预测指标。